Prescription drug · UNAPPROVED DRUG OTHER
Phospha 250 Neutral NDC 64980-729
Sodium phosphate, Dibasic, Anhydrous 852 mg/1 + 2 more ingredients · Tablet · Oral · Rising Pharma Holdings, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64980-729-01 | 6498007290164980072901 | 100 TABLET in 1 BOTTLE (64980-729-01)Marketed from Mar 28, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Phospha 250 Neutral
- Generic name (nonproprietary)
- dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate
- Active ingredients
- Sodium phosphate, Dibasic, Anhydrous — 852 mg/1Potassium phosphate, Monobasic — 155 mg/1Sodium phosphate, Monobasic, Monohydrate — 130 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Rising Pharma Holdings, Inc.NDC labeler code 64980
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 64980-729_f6c34864-dbd6-436e-b1e5-b1feaa61696aSPL ID f6c34864-dbd6-436e-b1e5-b1feaa61696aSPL set ID 9432adfc-6add-4ab4-ae93-2e2daf348be2RxCUI 200251, 656742UNII 22ADO53M6F, 4J9FJ0HL51, 593YOG76RNUPC 0364980729017
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464980072901followed by a unit qualifier and the quantityPackage 64980-0729-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE PHOSPHA 250 TM NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age.
Excerpt only. Read the full label for complete information.
About NDC 64980-729
- What is NDC 64980-729?
- 64980-729 is the product NDC for Phospha 250 Neutral, Sodium phosphate, Dibasic, Anhydrous 852 mg/1 + 2 more ingredients tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Phospha 250 Neutral (Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate).
- What is the active ingredient?
- Sodium phosphate, Dibasic, Anhydrous, Potassium phosphate, Monobasic, Sodium phosphate, Monobasic, Monohydrate.
- Who is the labeler?
- Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Phospha 250 Neutral?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.